Creato Flu GmbH: Innovative Broad Spectrum Oral Influenza Vaccine

POTSDAM, Germany--(BUSINESS WIRE)--Creato Flu GmbH announced today an innovative approach to develop a new broad-spectrum influenza vaccine. The live, orally active vaccine is expected to be effective against all types of influenza virus. “This vaccine is active in seasonal waves of influenza as well as occasional and unexpected outbreaks with pandemic potential, such as, for example, avian influenza or the current spreading of swine influenza,” announced Prof. Dr. Schramm, Chief Operating Officer of Creato Flu GmbH.